Illuminating Success in mRNA-Based Therapeutics
Advancing Innovation, Accelerating Delivery for Patient Impact
Closing notice: mRNA-Based Therapeutics Searchlight network
A chapter concludes in the journey of collaborative excellence
We're in the process of making some significant changes at Hanson Wade. As part of these changes, our mRNA -Based Therapeutics Searchlight network will be closing down.
However, this isn't the end of the road! We are excited to direct you towards other valuable opportunities and resources that Hanson Wade offers. Our commitment to providing industry-leading conferences, data and information products continues, and we believe these will be of great interest and value to you.
Hanson Wade specializes in scientific research across various drug modalities, key diseases, and R&D areas.
Browse our different products spanning 200+ conferences, networking groups, bespoke market research services, and databases. Discover how we can help inform your drug development decision-making to accelerate safer, more effective, and accessible drugs to patients in need.
Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space including oligonucleotide-based therapies, mRNA-based therapies, ribozyme therapies, gRNA-mediated gene editing therapies and RNA-targeted small molecules.